GPT and Decreased total leukocyte count: Clinical complications associated with SFTS are frequently observed during the second stage of the disease, characterized by neurologic symptoms, hemorrhagic manifestations, and disseminated intravascular coagulation (DIC), accompanied by exacerbated thrombocytopenia and leukopenia, as well as elevated levels of aspartate transaminase (AST), alanine transaminase (ALT), and lactate dehydrogenase (LDH) (12).